PAML and Axela Collaborate on Immune Status for Vaccine Preventable Diseases

Autor:	PR Newswire
Zdroj:	PR Newswire US. 04/27/2015.
Abstrakt:	SPOKANE, Wash., April 27, 2015 /PRNewswire/ -- PAML announced today that the laboratory has entered into a collaborative agreement with Axela, Inc. to develop multiplex assays focused on immune status for vaccine preventable diseases. PAML is one of the nation's leading medical reference laboratories, and Axela focuses on multiplexed nucleic acid and protein analysis for clinical diagnostics. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.